tirzepatide empower Meeting the Growing Demand for Compounded With the increasing need for effective weight management treatments, ensuring a reliable medication supply is more important than ever. We are happy to announce you Tirzepatide vs. Semaglutide for Weight

Brandt, L

To meet the diagnostic criteria for dEDS, a person must meet: Major criterion 1 AND major criterion 2 AND at least one other major criterion OR Major criterion 1 AND major criterion 2 AND at least three minor criteria Major Criteria Extreme skin fragility with congenital or postnatal skin tears Characteristic craniofacial features, which are evident at birth or early infancy or evolve later in childhood Redundant, almost lax skin, with excessive skin folds at the wrists and ankles Increased palmar wrinkling Severe bruisability with a risk of subcutaneous hematomas and hemorrhage Umbilical hernia Postnatal growth retardation Short limbs, hands, and feet Perinatal complications due to connective tissue fragility Minor Criteria Soft and doughy skin texture Skin hyperextensibility Atrophic scars Generalized joint hypermobility Complications of visceral fragility (e.g., bladder rupture, diaphragmatic rupture, rectal prolapse) Delayed motor development Osteopenia Hirsutism Tooth abnormalities Refractive errors (myopia, astigmatism) Strabismus Kyphoscoliotic EDS (kEDS) If a person meets the diagnostic criteria for kEDS, genetic testing should be done to confirm the diagnosis

The advantage of semaglutide lies in its established safety profile and widespread availability

Particular caution is warranted with insulin (hypoglycemia risk), sulfonylureas (hypoglycemia risk), blood thinners like warfarin (altered absorption), and oral contraceptives (potentially reduced efficacy)

10/09/21 - Added Amazon Affiliate links.

HSA and FSA accounts can cover PlexusDx medications, making long-term therapy more affordable